Cell cycle arrest in response to hypoxia is a fundamental physiological mechanism to maintain a balance between O 2 supply and demand. Many of the cellular responses to reduced O 2 availability are mediated through the transcriptional activity of hypoxia-inducible factor 1 (HIF-1). We report a role for the isolated HIF-1a subunit as an inhibitor of DNA replication, and this role was independent of HIF-1b and transcriptional regulation. In response to hypoxia, HIF-1a bound to Cdc6, a protein that is essential for loading of the minichromosome maintenance (MCM) complex (which has DNA helicase activity) onto DNA, and promoted the interaction between Cdc6 and the MCM complex. Although the interaction between Cdc6 and the MCM complex increased the association of the MCM proteins with chromatin, the binding of HIF-1a to the complex decreased phosphorylation and activation of the MCM complex by the kinase Cdc7. As a result, HIF-1a inhibited firing of replication origins, decreased DNA replication, and induced cell cycle arrest in various cell types. These findings establish a transcription-independent mechanism by which the stabilization of HIF-1a leads to cell cycle arrest in response to hypoxia.
INTRODUCTION
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that mediates adaptive responses to hypoxia. First identified in studies of erythropoietin gene expression (1), HIF-1 was subsequently shown to regulate oxygen homeostasis at both the cellular and systemic levels (2) (3) (4) . HIF-1 is a heterodimer composed of HIF-1a and HIF-1b subunits (5) . The abundance and activity of the HIF-1a subunit are regulated by O 2 -dependent hydroxylation (6) . Proline hydroxylation targets HIF-1a for ubiquitination by the von Hippel-Lindau ligase complex and subsequent proteasomal degradation (7) (8) (9) , whereas asparagine hydroxylation blocks interaction of HIF-1a with the coactivator p300 (10, 11) . These posttranslational modifications couple HIF-1 activity to the cellular O 2 concentration. Because the hydroxylases contain Fe(II) in their catalytic centers and use a-ketoglutarate (in addition to O 2 ) as a substrate, their activity can be inhibited by iron chelators, such as desferrioxamine (DFX), and by competitive antagonists of a-ketoglutarate, such as dimethyloxalylglycine (DMOG) (6) . HIF-1 regulates the expression of hundreds of target genes involved in angiogenesis, erythropoiesis, metabolism, autophagy, and other physiological responses to hypoxia (12) . The HIF-2a protein shares sequence similarity and functional overlap with HIF-1a, but its distribution is restricted to certain cell types, and in some cases, it mediates distinct biological functions (13) .
An imbalance between O 2 supply and consumption that results in hypoxia will be exacerbated by an increased number of cells. Consequently, a fundamental adaptation to hypoxia that is mediated by HIF-1a is reduced cell proliferation. Induction of HIF-1a by hypoxia leads to G 1 -phase cell cycle arrest in multiple cell types including various cancer cell lines (14) (15) (16) (17) , fibroblasts (18) , lymphocytes (18) , and hematopoietic stem cells (19) , and forced overexpression of HIF-1a, including under nonhypoxic conditions, is sufficient to inhibit cell proliferation (20) . The role of HIF-2a in cell cycle regulation is less clear and may be cell type-and stimulus-specific. Previous studies have reported that HIF-2a either arrests proliferation in a manner similar to HIF-1a (20) or increases cell proliferation (17) in a context-dependent manner. Thus far, studies examining the molecular mechanism by which HIF-1a mediates cell cycle arrest have focused on the role of HIF-1a in regulating the expression of the genes encoding p21 and p27 (15, 17, 18) , which inhibit the activity of cyclin-dependent kinases (CDKs).
The initiation of DNA replication is a tightly controlled process, the first steps of which are origin recognition, licensing, and activation, which involve formation (during the G 1 phase) of a multiprotein pre-replication complex (pre-RC) that marks all potential origins of replication (21) . Pre-RC formation begins with binding of the origin recognition complex (ORC), which is composed of six subunits (Orc1 to 6), to replication origins. ORC subsequently binds Cdc6 (22) and Cdt1 (23) , leading to recruitment of the minichromosome maintenance (MCM) helicase (24) , which is a hexamer consisting of MCM2 to 7, that functions to unwind DNA during replication (25) . However, Cdc6 and Cdt1 inhibit activation of the MCM helicase until the start of S phase (26) , when Cdc6 is phosphorylated by S phase CDKs, leading to its nuclear export and degradation (27, 28) . Inactivation of Cdc6 and Cdt1 allows Cdc7 to phosphorylate the MCM helicase at the start of S phase (29) , leading to its activation. Cdc45 subsequently binds to the helicase and recruits DNA polymerase a, which initiates DNA replication (30) .
Here, we report a role for the HIF-1a protein as a regulator of DNA helicase loading and activation. HIF-1a interacted with Cdc6 and promoted nuclear localization of Cdc6 and interaction with MCM proteins. This led to enhanced MCM helicase loading, but blocked subsequent recruitment of Cdc7, leading to decreased Cdc7-mediated phosphorylation and decreased replication origin firing. Induction of HIF-1a blocked replication origin firing and DNA replication in multiple cell types, which led to decreased cell proliferation.
RESULTS

HIF-1a inhibits cell proliferation in the absence of p21
On the basis of our previous discovery of interactions between HIF1a and MCM subunits (16), we hypothesized that HIF-1a may directly inhibit proliferation by effects on the pre-RC, independent of effects on p21 transcription. To test this hypothesis, we analyzed the cell cycle profiles of otherwise isogenic human HCT116 colorectal carcinoma cells that were either wild type or p21-null. G 1 phase cell cycle arrest was induced by hypoxia (1% O 2 ) in both wild-type and p21-null cells (Fig. 1A and fig.  S1A ). Similarly, chemical induction of HIF-1a by treatment of cells with DFX or DMOG led to a p21-independent decrease in bromodeoxyuridine (BrdU) incorporation (Fig. 1B) .
To verify that the cell cycle arrest induced by hypoxia, DMOG, or DFX was HIF-1a-dependent, we stably transfected HCT116 cells with either an empty short hairpin RNA (shRNA) vector (shEV) or vector encoding shRNA against HIF-1a (shHIF-1a). Immunoblot assays confirmed that HIF-1a abundance was decreased in cells expressing shHIF-1a, with no apparent effect on HIF-2a abundance (Fig. 1C) . HIF-1a knockdown blocked the G 1 phase cell cycle arrest induced by hypoxia ( Fig. 1D and  fig. S1B ), DMOG ( Fig. 1E and fig. S1C ), or DFX ( Fig. 1F and fig. S1D ).
HIF-1a interacts with Cdc6
The rapid time scale in which DNA replication was inhibited after induction of HIF-1a suggested a direct effect on the DNA replication machinery. To understand the effect of HIF-1a on the cell cycle, we performed binding assays between HIF-1a and various components of the pre-RC, including Orc2, Cdc6, and Cdt1. Endogenous HIF-1a coimmunoprecipitated with endogenous Cdc6 in hypoxic cell lysates from 293T, HCT116, and HeLa cells ( Fig. 2A) . Similarly, endogenous Cdc6 coimmunoprecipitated with endogenous HIF-1a from hypoxic cell lysates (Fig. 2B) . To ensure that the interaction was not an artifact of DNA bridging, we performed coimmunoprecipitations in the presence of the intercalating agent ethidium bromide (EtBr), which disrupts nonspecific protein interactions mediated by DNA (31) . The interaction of Cdc6 with HIF-1a was resistant to EtBr treatment (Fig. 2C) . Finally, we determined that Cdc6 bound to the N-terminal region of HIF-1a (residues 1 to 329) (Fig. 2D) , which is essential for inhibition of the cell cycle (15); HIF-1a bound to the N-terminal half of Cdc6 (Fig. 2E) .
HIF-1a promotes Cdc6 nuclear localization and chromatin association
Despite a readily detectable interaction between Cdc6 and HIF-1a, Cdc6 did not affect HIF-1a protein abundance ( fig. S2A ) or HIF-1 transcriptional activity ( fig. S2B ), as determined by immunoblot and reporter assays (32), respectively. However, confocal microscopy demonstrated a shift in Cdc6 localization from the cytoplasm to the nucleus in DMOG-treated cells (Fig. 3A) . Exposure of cells to hypoxia or DMOG significantly increased the number of cells with Cdc6-positive nuclei (Fig. 3B) . Similarly, induction of HIF-1a by exposure of cells to hypoxia or DMOG increased the abundance of endogenous Cdc6 in the chromatin fraction (Fig. 3, C and D) . However, a similar effect on Cdt1 was not observed (Fig. 3, C and D) . Knockdown of HIF-1a decreased the association of Cdc6 with chromatin upon DMOG treatment in HCT116 cells (Fig. 3E) . Exposure of normal human foreskin fibroblasts to hypoxia appeared to have similar effects (Fig. 3F) . Overexpression of HIF-1a was sufficient to increase the abundance of Cdc6 in the chromatin fraction of nonhypoxic HCT116 (Fig. 3G ), HeLa ( Fig. 3H) , and NIH-3T3 (Fig. 3I ) cells, which all arrest in response to hypoxia ( Fig. 1D and fig. S3 , A and B). The effect of HIF-1a on the association of Cdc6 with chromatin appeared to be maintained even in quiescent NIH-3T3 cells (Fig. 3J ), suggesting that this finding was not a secondary effect of cell cycle arrest induced by HIF-1a overexpression.
HIF-1a promotes interaction of Cdc6 with the MCM helicase
Because a key function of Cdc6 is to recruit the MCM helicase to origins of replication in an inactive state (33), we examined the effect of HIF-1a on the interaction of Cdc6 with the MCM helicase. DMOG treatment of HCT116 cells increased the colocalization of Cdc6 with MCM5 (Fig. 4 , A and B) and with MCM7 (Fig. 4C) . Overexpression of HIF-1a in HeLa cells led to an increase in the colocalization of Cdc6 with MCM5 ( Fig. 4D ) and with MCM7 (Fig. 4E) . Coimmunoprecipitation experiments demonstrated that despite an 80% reduction in total Cdc6 abundance, DMOG treatment appeared to enhance binding of endogenous Cdc6 to all members of the MCM complex that were analyzed (Fig. 4F ). HIF-1a knockdown blocked the increase in Cdc6-MCM interactions induced by exposure to hypoxia or treatment with DMOG ( Fig. 4G ), directly implicating HIF1a in promoting the interaction between Cdc6 and MCM proteins.
HIF-1a promotes loading of the MCM helicase
Consistent with an effect of HIF-1a on the association of Cdc6 with chromatin, confocal microscopy demonstrated an increase in MCM5 foci in the nuclei of cells treated with DMOG (Fig. 5A ). Overexpression of HIF-1a in nonhypoxic HeLa cells was sufficient to increase chromatin loading of MCM2 ( S4C ). Knockdown of HIF-1a reduced MCM chromatin loading in HCT116 cells (Fig. 5E ) and normal human foreskin fibroblasts (Fig. 5F ) exposed to 1% O 2 , further demonstrating that this is a physiologic response to hypoxia that is mediated by HIF-1a. Overexpression of HIF-1a or Cdc6 increased chromatin loading of MCM2 (Fig. 5G), MCM3 (Fig. 5H) , and MCM7 (Fig. 5I ) to comparable extents, and MCM loading was further increased by overexpression of both Cdc6 and HIF-1a (Fig. 5G) . Analysis of NIH-3T3 cells revealed a combined effect of HIF-1a and Cdc6 on MCM loading ( fig. S4 , D and E) in that cell line as well.
Effects of HIF-1a on MCM chromatin loading and activation are independent of transcription
The effect of HIF-1a overexpression was observed in cells that were cotransfected with a Cdc6 expression vector lacking any transcriptional or translational regulatory elements, which excluded a role for HIF-1a in increasing Cdc6 abundance through regulation of the Cdc6 promoter Lysates and immunoprecipitates from HCT116-shEV and HCT116-shHIF-1a cells that were untreated, treated with DMOG, or exposed to 1% O 2 were probed with anti-Cdc6, MCM2, MCM7, and HIF-1a antibodies. Western blot data from three independent replicates were quantified. Results are shown as means ± SEM. DMOG treatment or 1% O 2 exposure was compared to the untreated condition. *P < 0.05. (Fig. 3 , G to J). Hypoxia decreases Cdc6 mRNA expression in endothelial cells (34) , and, consistent with this report, we observed a decrease in the abundance of both Cdc6 mRNA (fig. S5A) and protein ( Fig. 4G and fig.  S5B ) upon exposure of cells to hypoxia or DMOG, whereas the abundance of another pre-RC component, Orc2, appeared to be unchanged ( fig. S5B ).
To determine whether HIF-1 transcriptional activity was required for the effects of HIF-1a on MCM chromatin loading, we generated two subclones that stably expressed shRNAs targeting two different sequences within HIF-1b mRNA, which were designated shHIF-1b-A and shHIF-1b-B. We confirmed that both shRNAs decreased HIF-1b mRNA abundance ( fig. S6A ). Both knockdown subclones showed impaired induction of HIF-1 reporter activity ( fig. S6B ) and impaired induction of the HIF-1 target gene VEGF (vascular endothelial growth factor) in response to hypoxia ( fig. S6C ). Enhanced loading of MCM proteins in response to hypoxia was preserved in both the shHIF-1b-A (Fig. 6A ) and shHIF-1b-B (Fig. 6B) subclones. Similarly, enhanced loading of MCM7 in response to HIF-1a overexpression was preserved in the subclone expressing shHIF-1b-A (Fig. 6C) or shHIF-1b-B (Fig. 6D) .
We also observed that an R27G mutation in HIF-1a that abolishes the DNA binding activity of HIF-1 (15) had no effect on the ability of HIF-1a to increase Cdc6 chromatin association (Fig. 6E) . Similarly, the R27G mutation had no effect on the ability of HIF-1a to increase the association of MCM5 (Fig. 6F) and MCM7 ( Fig. 6G ) with chromatin. On the basis of these results, we concluded that the effects of HIF-1a on MCM chromatin loading were independent of HIF-1 transcriptional activity.
The N-terminal region of HIF-1a contains binding sites for Cdc6 (Fig. 2D ) and MCM proteins (16) . Expression of the HIF-1a (1 to 329) deletion fragment, which lacks the C-terminal transactivation domains, was sufficient to increase the chromatin localization of Cdc6 (Fig. 6H) , as well as that of MCM2 (Fig. 6I), MCM5 (Fig. 6J) , and MCM7 (Fig. 6K) . We conclude that the Cdc6-and MCM-interacting binding domains in the N-terminal half of HIF-1a are sufficient to regulate MCM chromatin loading independent of transcriptional activation.
HIF-1a blocks Cdc7-mediated activation of the MCM helicase Cdc6 inhibits helicase activation by blocking Cdc7-mediated phosphorylation of the MCM helicase (26) . We hypothesized that the Cdc6-mediated increase in MCM chromatin loading was associated with an inhibition of helicase activation. Consistent with this hypothesis, we observed decreased abundance of chromatin-bound Cdc7 in hypoxic HCT116 cells, whereas no effect on total Cdc7 abundance was observed (Fig. 7A) . In NIH-3T3 cells, DFX or DMOG treatment decreased the abundance of chromatin-bound Cdc7 (Fig. 7, B and C) . Induction of HIF-1a by exposure to DMOG or hypoxia led to decreased Cdc7-mediated phosphorylation of MCM2 (Fig. 7D) . Despite increased MCM2 chromatin loading upon exposure to hypoxia, phosphorylation of MCM2 in the chromatin fraction was decreased (Fig. 7E) . Similar results were obtained in HeLa cells (Fig. 7F) . In contrast, hypoxia did not affect the phosphorylation of MCM2 in WT8 cells (Fig. 7G) , which lack HIF-1a and do not arrest in response to hypoxia (17) .
Consistent with a decrease in MCM helicase activation, hypoxic HCT116 cells showed a decrease in the abundance of Cdc45 in the chromatin fraction, which serves as a direct indicator of active replication origins (Fig. 7H) . Conversely, HIF-1a knockdown was sufficient to increase chromatin-bound Cdc7 abundance in HCT116 cells exposed to DMOG (Fig. 7I) or hypoxia (Fig. 7J) . Similarly, the abundance of chromatin-bound Cdc45 was increased upon HIF-1a knockdown (Fig. 7, I and J). However, HIF-1a knockdown did not appear to alter the abundance of Orc2, an upstream component of the pre-RC (Fig. 7, I and J). Together, these results indicate that by increasing the abundance of chromatin-bound Cdc6, HIF-1a enhances chromatin loading of MCMs but inhibits Cdc7-mediated phosphorylation and activation of the MCM helicase.
HIF-1a inhibits replication origin firing
To investigate whether the observed effects of HIF-1a lead to altered replication origin firing, we pulse-labeled untreated or DMOG-treated cells with BrdU to visualize sites of DNA synthesis. DMOG treatment decreased not only the number of BrdU + cells (Fig. 8A ) but also the number of foci of DNA synthesis in BrdU + cells (Fig. 8B) . We next tested whether HIF1a overexpression was sufficient to inhibit DNA synthesis. The fraction of cells undergoing DNA replication was significantly lower in cells transfected with an HIF-1a expression vector than in cells transfected with an empty vector (Fig. 8C) , as was the number of foci of DNA synthesis in replicating cells (Fig. 8D) .
To complement the observations in cell lines, we examined the effect of HIF-1a on DNA synthesis in primary human newborn foreskin fibroblasts. Exposing cells to hypoxia or DMOG led to a decreased percentage of replicating cells (Fig. 8E) and a decrease in the number of foci of DNA synthesis in replicating cells (Fig. 8F) . The effects of hypoxia and DMOG on DNA synthesis were blunted in HIF-1a knockdown cells (Fig. 8, E and F) . Together, these results indicate that hypoxia inhibits DNA replication in mammalian cells and that increased HIF-1a protein abundance induces this response. To exclude a role for HIF-1-mediated transcription, we analyzed the effect on BrdU incorporation using the R27G mutant that is defective in DNA binding and transcriptional activity. The R27G mutation did not affect the ability of HIF-1a to inhibit BrdU incorporation (Fig. 8, G and H) . Similarly, overexpression of HIF-1a (1 to 329), which lacks the C-terminal transactivation domains, decreased the number (Fig. 8I) of BrdU + cells and DNA synthesis in replicating cells (Fig. 8J) . We conclude that HIF-1a serves a nontranscriptional role as a direct regulator of DNA replication and cell cycle progression.
DISCUSSION
The regulation of cell proliferation according to O 2 availability is a fundamental physiological response of mammalian cells. Here, we have delineated a mechanism by which DNA replication is inhibited in response to hypoxia (Fig. 9) . We have demonstrated that HIF-1a interacts with Cdc6, increases the abundance of chromatin-bound Cdc6, and promotes Cdc6 interaction with the MCM helicase, which is associated with increased chromatin loading of the MCM complex but decreased recruitment of the kinase Cdc7 as well as decreased phosphorylation and activation of the MCM helicase, leading to reduced replication origin firing.
The mechanisms by which hypoxia affects cell proliferation have been controversial. Multiple studies in diverse cell lines, which implicated HIFs in this process, have focused mechanistically on effects mediated through increased expression of genes encoding the CDK inhibitors p21 (15, 17) , p27 (35), or both (36) . In certain cancer cell lines, a HIF-independent effect on cyclin D1 has also been reported (37, 38) . Previous work has suggested that, in certain cases, the relative abundance of HIF-1a as opposed to HIF-2a determines the sensitivity of the cell cycle to hypoxia through transcriptional effects (17) .
Our study delineates a mechanism by which HIF-1a can immediately block DNA replication by directly binding to components of the pre-RC. Multiple lines of experimental evidence indicate that this role of HIF-1a is independent of transcriptional activity. First, the effects on BrdU incorporation were detectable within 6 hours of HIF-1a induction, a time scale inconsistent with effects mediated through new gene transcription and translation. Second, the effects of HIF-1a overexpression were observed in cells transfected with Cdc6 and MCM expression vectors that lacked any transcriptional or translational regulatory elements. Hypoxia, in fact, decreased mRNA and protein abundance of Cdc6 and the MCM components (16), indicating that the increased Cdc6 and MCM chromatin loading that was mediated by HIF-1a did not result from changes in the abundance of these proteins. Third, the proliferation of HIF-1b knockdown cells was reduced in response to hypoxia. The abundance of HIF-1a increased in these cells after exposure to hypoxia, but induction of HIF-1 target genes, which requires activity of the HIF-1a/HIF-1b heterodimer, was impaired. Nonetheless, the effect of HIF-1a overexpression and hypoxic induction of HIF-1a on the MCM helicase was preserved in these cell lines. Fourth, a point mutant of HIF-1a with impaired DNA binding retained effects on the Cdc6 and MCM proteins. Finally, a HIF-1a deletion mutant retaining only the Cdc6-and MCM-interacting domains, but lacking transactivation domains, mediated the antiproliferative effects of fulllength HIF-1a. Our data establish a paradigm in which HIF-1a, by binding and regulating the activity of protein complexes, may exert biological effects through rapid, nontranscriptional mechanisms.
We demonstrated the effects of HIF-1a on the MCM helicase in various cell types, including HCT116 colorectal carcinoma cells, HeLa cervical carcinoma cells, NIH-3T3 mouse fibroblasts, and newborn foreskin fibroblasts. However, certain cell types, including some cancer cells, maintain cell proliferation under hypoxic conditions. We previously demonstrated that, in addition to their role as a helicase, multiple MCM proteins bind to and enhance the degradation of HIF-1a (16), thereby providing a mechanism by which proliferative signals can override the effect of hypoxia on the cell cycle. Together with the data presented here, a model emerges in which a dynamic and mutually antagonistic balance between HIF-1a and MCM proteins, sensitive to both hypoxia and proliferative signals, regulates the cellular decision to arrest or maintain proliferation under hypoxic conditions. While this manuscript was in preparation, another group reported that under conditions of severe hypoxia (<0.1% O 2 ), during which MCM helicase loading is inhibited (39) , an HIF-independent decrease in Cdc6 abundance becomes limiting (40) . Previous work has established that severe hypoxia leads to increased activity of the kinase ATR (ataxia telangiectasia) (41), even in the absence of DNA damage (42) . Increased kinase activity of ATR may underlie the observed decrease in Cdc6 abundance during severe hypoxia (40) . We demonstrated a decrease in Cdc6 mRNA and protein abundance, even under more moderate hypoxia ( fig. S5, A and B) , which appeared to be hydroxylase-dependent but HIF-1a-independent (Fig. 4G) . We observed that total MCM protein abundance also decreased after prolonged exposure to hypoxia (16) . However, under moderate hypoxia, the decrease in total Cdc6 or MCM protein abundance was not sufficiently limiting to decrease Cdc6 or MCM abundance in chromatin. Together with our study, these results suggest that hypoxia regulates MCM helicase activity through multiple mechanisms depending on the duration and severity of the hypoxic stimulus. The acute response to moderate (physiological) hypoxia is reversible upon reoxygenation, whereas the response to chronic or severe (pathological) hypoxia is longer lasting because of the need for new synthesis of pre-RC components. Under physiological conditions, the mutual antagonism of HIFs and MCMs provides a potential mechanism for cell type-specific proliferative responses to hypoxia based on the relative balance between HIFs and MCMs. Despite dysregulated cell proliferation, many cancer cells still undergo cell cycle arrest in response to hypoxia and are therefore resistant to the effect of cytotoxic chemotherapy, which targets dividing cells. Our results suggest that drugs that inhibit HIF-1a accumulation (43) may render hypoxic cancer cells sensitive to chemotherapy.
MATERIALS AND METHODS
Tissue culture
The 293T, NIH-3T3, HeLa, and WT8 cell lines and newborn foreskin fibroblasts were cultured in Dulbecco's modified Eagle's medium, and HCT116 cells were cultured in McCoy Medium 5A, all supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were maintained at 37°C in a 5% CO 2 , 95% air incubator. Cells were subjected to hypoxia by exposure to 1% O 2 /5% CO 2 /balance N 2 at 37°C in a modular incubator chamber (Billups-Rothenberg). DFX (Sigma) was used at a dose of 100 mM, and DMOG (Sigma) was used at a dose of 1 mM.
Immunoprecipitation and immunoblot assays
Cells were lysed in phosphate-buffered saline (PBS) with 0.1% Tween 20, 1 mM dithiothreitol (DTT), protease inhibitor cocktail, 1 mM Na 3 VO 4 , and 10 mM NaF, followed by gentle sonication. For immunoprecipitation assays, 30 ml of anti-V5 agarose beads (Sigma) was incubated with 2.5 mg of cell lysate overnight at 4°C. Beads were washed four times in lysis buffer. Proteins were eluted in SDS sample buffer and fractionated by SDS-polyacrylamide gel electrophoresis. The following antibodies were used in immunoblot and immunoprecipitation assays: histone H3, Cdc6, and b-actin (Santa Cruz Biotechnology); HIF-1a (BD Biosciences); FLAG (Sigma); and MCM2, phospho-MCM2 (Ser 41 ), MCM5, MCM7, Cdt1, Cdc6, Cdc7, Cdc45, Orc2, and Myc epitope (Novus Biologicals).
Reverse transcription-quantitative real-time polymerase chain reaction assay Total RNA was extracted from 293T cells using TRIzol (Invitrogen) and was treated with DNase I (Ambion). Total RNA (1 mg) was used for firststrand synthesis with the iScript cDNA Synthesis system (Bio-Rad). Real-time polymerase chain reaction (PCR) was performed with iQ SYBR Green Supermix and iCycler Real-Time PCR Detection System (Bio-Rad). Expression of target mRNA relative to 18S ribosomal RNA (rRNA) was calculated on the basis of the threshold cycle (C T ) for amplification as 2 −DC T , where DC T = C T,target − C T,18S . Primer sequences used were as follows: 18S rRNA, 5′-cggcgacgacccattcgaac-3′ and 5′-gaatcgaaccctgattccccgtc-3′; VEGF mRNA, 5′-cttgccttgctgctctac-3′ and 5′-tggcttgaagatgtactgg-3′; and HIF-1b, 5′-ctgccaaccccgaaatgacat-3′ and 5′-gccgcttaatagccctctgg-3′.
Immunofluorescence assay
Immunofluorescence was performed as previously described (44) . HCT116 cells were plated on gelatin-coated glass-bottomed plates (LiveAssay, LA-RD1.5UNC) and exposed to hypoxia or hydroxylase inhibitor for 18 hours. For immunocytochemistry, samples were washed with ice-cold PBS, fixed with ethanol for 20 min at room temperature, permeabilized with 0.05% Triton X-100 for 15 min, washed twice with PBS, and blocked with 10% goat serum/1% AlbuMAX (Invitrogen) for 1 hour. Samples were incubated with primary antibody for 1 hour, washed, and incubated with Alexa Fluor-conjugated secondary antibody (Invitrogen) for 1 hour. Samples were washed and mounted to microscopy slides with a drop of SlowFade (Invitrogen) and sealed with medical adhesive (Hollister).
Microscopy
Phase contrast microscopy was performed with Nikon SPOT 2.0. Images were acquired using SPOT Insight 2MP camera with SPOT Imaging software (Diagnostic Instruments) and processed using Photoshop (Adobe Systems). Epifluorescence microscopy was performed with an Axiovert 2000 (Zeiss) using 10×, 20×, and 40× apochromat objective lenses with 1.4 numerical aperture (NA). Lambda LS xenon arc lamp (Sutter Instrument) was used for excitation, and acquisition was performed with a Cascade 512BII camera (Roper Scientific). Images were acquired and processed using Slidebook 4.2.0 (Intelligent Imaging Innovations), and processing was performed with Adobe Photoshop. Confocal microscopy was performed with an LSM 510 Meta CLSM (Zeiss) using 20× and 40× apochromat objective lens with 1.4 NA. Pinholes were adjusted to 1 mm. For excitation, a blue diode (405 nm), a green argon laser (488 nm), and a red HeNe laser (568 nm) were used. Images were processed using Meta software version 3.5 (Zeiss). Computational analysis was performed with custom software written using MATLAB 6.0.
Cell cycle analysis
Otherwise isogenic wild-type and p21-null HCT116 cells (45) were fixed in 70% ethanol, stained with propidium iodide, and analyzed by fluorescenceactivated cell sorting. Data were acquired in an LSR II flow cytometer (Becton Dickinson). A minimum of 10,000 events per sample were recorded. Analysis of cell cycle phases was modeled using the Dean-Jett-Fox algorithm (46) .
Chromatin isolation
Chromatin fraction was isolated as previously described (47) . Briefly, cells were washed with PBS, pelleted, and lysed with cytoskeleton buffer [20 mM Hepes (pH 7.8), 10 mM KCl, 2 mM EDTA, 300 mM sucrose, 0.5% Triton X-100, with protease inhibitors and phenylmethylsulfonyl fluoride]. After incubation on ice for 10 min, samples were centrifuged, and the pellet was isolated. This process was repeated twice, after which the pellets were suspended in 10 mM Hepes (pH 7.8), 2 mM EDTA, 0.3 mM EGTA, and 1 mM DTT. Samples were sonicated, and protein concentrations were normalized before immunoblot assay.
Statistical analysis
Data are presented as means ± SEM, except where otherwise noted. Differences between two conditions were analyzed using Student's t test. Normalized Western blot data were analyzed using a one-sample t test against a theoretical mean of 1. Differences between three variables were analyzed by two-way analysis of variance (ANOVA) with Bonferroni correction.
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